A human T-cell lymphotropic virus type I carrier with temporal arteritis terminating in acute myelogenous leukemia.
A human T-cell lymphotropic virus type I (HTLV-I) carrier with temporal arteritis (TA) in whom acute myelogenous leukemia (AML) developed 1 year after successful treatment of the autoimmune disease is described. This case suggested that the induction of immunodeficiency by infection with HTLV-I may be related to the development of the autoimmune disease and malignancy.
Department of Internal Medicine, Saga Medical School, Japan.
Y
Y
Shimamoto
C
C
Matsunaga
K
K
Suga
N
N
Fukushima
K
K
Nomura
M
M
Yamaguchi
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002353:Carrier State; D005260:Female; D013700:Giant Cell Arteritis / Q000188:drug therapy / Q000382:microbiology*; D015490:HTLV-I Infections / Q000150:complications*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000209:etiology*; D011239:Prednisolone / Q000627:therapeutic use
D011239:Prednisolone